Management of soft tissue sarcoma
Identifieur interne : 000143 ( Istex/Corpus ); précédent : 000142; suivant : 000144Management of soft tissue sarcoma
Auteurs : M. E. Pitcher ; S. Fish ; S. ThomasSource :
- British Journal of Surgery [ 0007-1323 ] ; 1994-08.
Abstract
A total of 485 patients with a proven or suspected diagnosis of soft tissue sarcoma were referred over a 3‐year period. Of these, 61 were referred for opinion only and 424 for definitive treatment. Overall there were 223 patients with primary soft tissue sarcoma and 84 with recurrent sarcoma, 84 with benign soft tissue tumours and 22 with non‐soft tissue sarcoma malignancy; 11 patients were referred with known metastatic disease. The commonest benign tumours mimicking soft tissue sarcoma were fibromatosis and benign intermuscular or intramuscular lipoma. The malignant tumours suspected clinically of being soft tissue sarcoma were bone tumours, lymphoma and metastatic carcinoma. Of the 172 patients with primary soft tissue sarcoma referred with a proven diagnosis this had been established by excision biopsy in 94 and open incision biopsy in 48. By contrast, of those undiagnosed at referral, 44 of 51 patients with soft tissue sarcoma had the diagnosis made by Tru‐cut core biopsy. Amputation was performed in four of 165 patients with primary extremity soft tissue sarcoma and in five of 54 with recurrent extremity sarcoma, giving an overall amputation rate of 4 per cent. It is proposed that the amputation rate for extremity soft tissue sarcoma can be reduced by the use of reconstructive procedures, particularly myocutaneous flaps to the proximal limbs and limb girdles, and free vascularized flaps to sites distal to the midthigh and midarm.
Url:
DOI: 10.1002/bjs.1800810817
Links to Exploration step
ISTEX:03188AADB95347E856A2C88C9E551D3361A6BC90Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management of soft tissue sarcoma</title><author><name sortKey="Pitcher, M E" sort="Pitcher, M E" uniqKey="Pitcher M" first="M. E." last="Pitcher">M. E. Pitcher</name><affiliation><mods:affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</mods:affiliation></affiliation></author><author><name sortKey="Fish, S" sort="Fish, S" uniqKey="Fish S" first="S." last="Fish">S. Fish</name><affiliation><mods:affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</mods:affiliation></affiliation></author><author><name sortKey="Thomas, S" sort="Thomas, S" uniqKey="Thomas S" first="S." last="Thomas">S. Thomas</name><affiliation><mods:affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:03188AADB95347E856A2C88C9E551D3361A6BC90</idno><date when="1994" year="1994">1994</date><idno type="doi">10.1002/bjs.1800810817</idno><idno type="url">https://api.istex.fr/document/03188AADB95347E856A2C88C9E551D3361A6BC90/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000143</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000143</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Management of soft tissue sarcoma</title><author><name sortKey="Pitcher, M E" sort="Pitcher, M E" uniqKey="Pitcher M" first="M. E." last="Pitcher">M. E. Pitcher</name><affiliation><mods:affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</mods:affiliation></affiliation></author><author><name sortKey="Fish, S" sort="Fish, S" uniqKey="Fish S" first="S." last="Fish">S. Fish</name><affiliation><mods:affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</mods:affiliation></affiliation></author><author><name sortKey="Thomas, S" sort="Thomas, S" uniqKey="Thomas S" first="S." last="Thomas">S. Thomas</name><affiliation><mods:affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">British Journal of Surgery</title><title level="j" type="alt">BRITISH JOURNAL OF SURGERY</title><idno type="ISSN">0007-1323</idno><idno type="eISSN">1365-2168</idno><imprint><biblScope unit="vol">81</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="1136">1136</biblScope><biblScope unit="page" to="1139">1139</biblScope><biblScope unit="page-count">4</biblScope><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Bristol</pubPlace><date type="published" when="1994-08">1994-08</date></imprint><idno type="ISSN">0007-1323</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0007-1323</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A total of 485 patients with a proven or suspected diagnosis of soft tissue sarcoma were referred over a 3‐year period. Of these, 61 were referred for opinion only and 424 for definitive treatment. Overall there were 223 patients with primary soft tissue sarcoma and 84 with recurrent sarcoma, 84 with benign soft tissue tumours and 22 with non‐soft tissue sarcoma malignancy; 11 patients were referred with known metastatic disease. The commonest benign tumours mimicking soft tissue sarcoma were fibromatosis and benign intermuscular or intramuscular lipoma. The malignant tumours suspected clinically of being soft tissue sarcoma were bone tumours, lymphoma and metastatic carcinoma. Of the 172 patients with primary soft tissue sarcoma referred with a proven diagnosis this had been established by excision biopsy in 94 and open incision biopsy in 48. By contrast, of those undiagnosed at referral, 44 of 51 patients with soft tissue sarcoma had the diagnosis made by Tru‐cut core biopsy. Amputation was performed in four of 165 patients with primary extremity soft tissue sarcoma and in five of 54 with recurrent extremity sarcoma, giving an overall amputation rate of 4 per cent. It is proposed that the amputation rate for extremity soft tissue sarcoma can be reduced by the use of reconstructive procedures, particularly myocutaneous flaps to the proximal limbs and limb girdles, and free vascularized flaps to sites distal to the midthigh and midarm.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>sarcoma</json:string><json:string>tumour</json:string><json:string>soft tissue sarcoma</json:string><json:string>tissue sarcoma</json:string><json:string>amputation</json:string><json:string>radiotherapy</json:string><json:string>excision</json:string><json:string>core biopsy</json:string><json:string>metastatic</json:string><json:string>soft tissue sarcomas</json:string><json:string>biopsy</json:string><json:string>recurrence</json:string><json:string>flaps</json:string><json:string>incision</json:string><json:string>soft tissue</json:string><json:string>metastasis</json:string><json:string>excision biopsy</json:string><json:string>local recurrence rate</json:string><json:string>benign</json:string><json:string>tissue sarcomas</json:string><json:string>local recurrence</json:string><json:string>recurrent disease</json:string><json:string>soft tissue tumours</json:string><json:string>metastatic disease</json:string><json:string>open incision biopsy</json:string><json:string>tissue tumours</json:string><json:string>limb girdles</json:string><json:string>recurrent sarcoma</json:string><json:string>intramuscular lipoma</json:string><json:string>definitive treatment</json:string><json:string>extremity sarcoma</json:string><json:string>benign intermuscular</json:string><json:string>deep fascia</json:string><json:string>recurrent tumour</json:string><json:string>limb girdle</json:string></teeft></keywords><author><json:item><name>M. E. Pitcher</name><affiliations><json:string>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</json:string></affiliations></json:item><json:item><name>S. Fish</name><affiliations><json:string>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</json:string></affiliations></json:item><json:item><name>Mr Thomas</name><affiliations><json:string>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</json:string><json:string>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</json:string></affiliations></json:item></author><articleId><json:string>BJS1800810817</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>A total of 485 patients with a proven or suspected diagnosis of soft tissue sarcoma were referred over a 3‐year period. Of these, 61 were referred for opinion only and 424 for definitive treatment. Overall there were 223 patients with primary soft tissue sarcoma and 84 with recurrent sarcoma, 84 with benign soft tissue tumours and 22 with non‐soft tissue sarcoma malignancy; 11 patients were referred with known metastatic disease. The commonest benign tumours mimicking soft tissue sarcoma were fibromatosis and benign intermuscular or intramuscular lipoma. The malignant tumours suspected clinically of being soft tissue sarcoma were bone tumours, lymphoma and metastatic carcinoma. Of the 172 patients with primary soft tissue sarcoma referred with a proven diagnosis this had been established by excision biopsy in 94 and open incision biopsy in 48. By contrast, of those undiagnosed at referral, 44 of 51 patients with soft tissue sarcoma had the diagnosis made by Tru‐cut core biopsy. Amputation was performed in four of 165 patients with primary extremity soft tissue sarcoma and in five of 54 with recurrent extremity sarcoma, giving an overall amputation rate of 4 per cent. It is proposed that the amputation rate for extremity soft tissue sarcoma can be reduced by the use of reconstructive procedures, particularly myocutaneous flaps to the proximal limbs and limb girdles, and free vascularized flaps to sites distal to the midthigh and midarm.</abstract><qualityIndicators><score>6.111</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 792 pts (letter)</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1459</abstractCharCount><pdfWordCount>3351</pdfWordCount><pdfCharCount>20878</pdfCharCount><pdfPageCount>4</pdfPageCount><abstractWordCount>230</abstractWordCount></qualityIndicators><title>Management of soft tissue sarcoma</title><genre><json:string>article</json:string></genre><host><title>British Journal of Surgery</title><language><json:string>unknown</json:string></language><doi><json:string>10.1002/(ISSN)1365-2168</json:string></doi><issn><json:string>0007-1323</json:string></issn><eissn><json:string>1365-2168</json:string></eissn><publisherId><json:string>BJS</json:string></publisherId><volume>81</volume><issue>8</issue><pages><first>1136</first><last>1139</last><total>4</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Original Article</value></json:item></subject></host><categories><wos><json:string>science</json:string><json:string>surgery</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>surgery</json:string></scienceMetrix><inist><json:string>sciences appliquees, technologies et medecines</json:string><json:string>sciences biologiques et medicales</json:string><json:string>sciences medicales</json:string></inist></categories><publicationDate>1994</publicationDate><copyrightDate>1994</copyrightDate><doi><json:string>10.1002/bjs.1800810817</json:string></doi><id>03188AADB95347E856A2C88C9E551D3361A6BC90</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/03188AADB95347E856A2C88C9E551D3361A6BC90/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/03188AADB95347E856A2C88C9E551D3361A6BC90/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/03188AADB95347E856A2C88C9E551D3361A6BC90/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Management of soft tissue sarcoma</title></titleStmt><publicationStmt><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Bristol</pubPlace><availability><licence>Copyright © 1994 British Journal of Surgery Society Ltd.</licence></availability><date type="published" when="1994-08"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main" xml:lang="en">Management of soft tissue sarcoma</title><title level="a" type="short" xml:lang="en">SOFT TISSUE SARCOMA</title><author xml:id="author-0000"><persName><forename type="first">M. E.</forename><surname>Pitcher</surname></persName><affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK<address><country key="GB"></country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">S.</forename><surname>Fish</surname></persName><affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK<address><country key="GB"></country></address></affiliation></author><author xml:id="author-0002" role="corresp"><persName><addName>Mr</addName><forename type="first">J. M.</forename><surname>Thomas</surname></persName><affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK<address><country key="GB"></country></address></affiliation><affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</affiliation></author><idno type="istex">03188AADB95347E856A2C88C9E551D3361A6BC90</idno><idno type="DOI">10.1002/bjs.1800810817</idno><idno type="unit">BJS1800810817</idno><idno type="toTypesetVersion">file:BJS.BJS1800810817.pdf</idno></analytic><monogr><title level="j" type="main">British Journal of Surgery</title><title level="j" type="alt">BRITISH JOURNAL OF SURGERY</title><idno type="pISSN">0007-1323</idno><idno type="eISSN">1365-2168</idno><idno type="book-DOI">10.1002/(ISSN)1365-2168</idno><idno type="book-part-DOI">10.1002/bjs.v81:8</idno><idno type="product">BJS</idno><imprint><biblScope unit="vol">81</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="1136">1136</biblScope><biblScope unit="page" to="1139">1139</biblScope><biblScope unit="page-count">4</biblScope><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Bristol</pubPlace><date type="published" when="1994-08"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><abstract xml:lang="en" style="main"><head>Abstract</head><p>A total of 485 patients with a proven or suspected diagnosis of soft tissue sarcoma were referred over a 3‐year period. Of these, 61 were referred for opinion only and 424 for definitive treatment. Overall there were 223 patients with primary soft tissue sarcoma and 84 with recurrent sarcoma, 84 with benign soft tissue tumours and 22 with non‐soft tissue sarcoma malignancy; 11 patients were referred with known metastatic disease. The commonest benign tumours mimicking soft tissue sarcoma were fibromatosis and benign intermuscular or intramuscular lipoma. The malignant tumours suspected clinically of being soft tissue sarcoma were bone tumours, lymphoma and metastatic carcinoma. Of the 172 patients with primary soft tissue sarcoma referred with a proven diagnosis this had been established by excision biopsy in 94 and open incision biopsy in 48. By contrast, of those undiagnosed at referral, 44 of 51 patients with soft tissue sarcoma had the diagnosis made by Tru‐cut core biopsy. Amputation was performed in four of 165 patients with primary extremity soft tissue sarcoma and in five of 54 with recurrent extremity sarcoma, giving an overall amputation rate of 4 per cent. It is proposed that the amputation rate for extremity soft tissue sarcoma can be reduced by the use of reconstructive procedures, particularly myocutaneous flaps to the proximal limbs and limb girdles, and free vascularized flaps to sites distal to the midthigh and midarm.</p></abstract><textClass><classCode scheme="articleCategory">Original Article</classCode><classCode scheme="tocHeading1">Original Articles</classCode></textClass><langUsage><language ident="EN"></language></langUsage></profileDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/03188AADB95347E856A2C88C9E551D3361A6BC90/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>John Wiley & Sons, Ltd.</publisherName><publisherLoc>Bristol</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1365-2168</doi><issn type="print">0007-1323</issn><issn type="electronic">1365-2168</issn><idGroup><id type="product" value="BJS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="BRITISH JOURNAL OF SURGERY">British Journal of Surgery</title><title type="short">Br J Surg</title></titleGroup></publicationMeta><publicationMeta level="part" position="80"><doi origin="wiley" registered="yes">10.1002/bjs.v81:8</doi><numberingGroup><numbering type="journalVolume" number="81">81</numbering><numbering type="journalIssue">8</numbering></numberingGroup><coverDate startDate="1994-08">August 1994</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="17" status="forIssue"><doi origin="wiley" registered="yes">10.1002/bjs.1800810817</doi><idGroup><id type="unit" value="BJS1800810817"></id></idGroup><countGroup><count type="pageTotal" number="4"></count></countGroup><titleGroup><title type="articleCategory">Original Article</title><title type="tocHeading1">Original Articles</title></titleGroup><copyright ownership="thirdParty">Copyright © 1994 British Journal of Surgery Society Ltd.</copyright><eventGroup><event type="manuscriptAccepted" date="1993-12-21"></event><event type="firstOnline" date="2005-12-08"></event><event type="publishedOnlineFinalForm" date="2005-12-08"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.1 mode:FullText source:HeaderRef result:HeaderRef" date="2010-02-23"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-07"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-15"></event></eventGroup><numberingGroup><numbering type="pageFirst">1136</numbering><numbering type="pageLast">1139</numbering></numberingGroup><correspondenceTo>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:BJS.BJS1800810817.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="4"></count><count type="referenceTotal" number="27"></count></countGroup><titleGroup><title type="main" xml:lang="en">Management of soft tissue sarcoma</title><title type="short" xml:lang="en">SOFT TISSUE SARCOMA</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>M. E.</givenNames><familyName>Pitcher</familyName></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>S.</givenNames><familyName>Fish</familyName></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><honorifics>Mr</honorifics><givenNames>J. M.</givenNames><familyName>Thomas</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="GB" type="organization"><unparsedAffiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</unparsedAffiliation></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>A total of 485 patients with a proven or suspected diagnosis of soft tissue sarcoma were referred over a 3‐year period. Of these, 61 were referred for opinion only and 424 for definitive treatment. Overall there were 223 patients with primary soft tissue sarcoma and 84 with recurrent sarcoma, 84 with benign soft tissue tumours and 22 with non‐soft tissue sarcoma malignancy; 11 patients were referred with known metastatic disease. The commonest benign tumours mimicking soft tissue sarcoma were fibromatosis and benign intermuscular or intramuscular lipoma. The malignant tumours suspected clinically of being soft tissue sarcoma were bone tumours, lymphoma and metastatic carcinoma. Of the 172 patients with primary soft tissue sarcoma referred with a proven diagnosis this had been established by excision biopsy in 94 and open incision biopsy in 48. By contrast, of those undiagnosed at referral, 44 of 51 patients with soft tissue sarcoma had the diagnosis made by Tru‐cut core biopsy. Amputation was performed in four of 165 patients with primary extremity soft tissue sarcoma and in five of 54 with recurrent extremity sarcoma, giving an overall amputation rate of 4 per cent. It is proposed that the amputation rate for extremity soft tissue sarcoma can be reduced by the use of reconstructive procedures, particularly myocutaneous flaps to the proximal limbs and limb girdles, and free vascularized flaps to sites distal to the midthigh and midarm.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Management of soft tissue sarcoma</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>SOFT TISSUE SARCOMA</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Management of soft tissue sarcoma</title></titleInfo><name type="personal"><namePart type="given">M. E.</namePart><namePart type="family">Pitcher</namePart><affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Fish</namePart><affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="termsOfAddress">Mr</namePart><namePart type="family">Thomas</namePart><affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</affiliation><affiliation>Department of Surgery, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>John Wiley & Sons, Ltd.</publisher><place><placeTerm type="text">Bristol</placeTerm></place><dateIssued encoding="w3cdtf">1994-08</dateIssued><dateValid encoding="w3cdtf">1993-12-21</dateValid><copyrightDate encoding="w3cdtf">1994</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">4</extent><extent unit="references">27</extent></physicalDescription><abstract lang="en">A total of 485 patients with a proven or suspected diagnosis of soft tissue sarcoma were referred over a 3‐year period. Of these, 61 were referred for opinion only and 424 for definitive treatment. Overall there were 223 patients with primary soft tissue sarcoma and 84 with recurrent sarcoma, 84 with benign soft tissue tumours and 22 with non‐soft tissue sarcoma malignancy; 11 patients were referred with known metastatic disease. The commonest benign tumours mimicking soft tissue sarcoma were fibromatosis and benign intermuscular or intramuscular lipoma. The malignant tumours suspected clinically of being soft tissue sarcoma were bone tumours, lymphoma and metastatic carcinoma. Of the 172 patients with primary soft tissue sarcoma referred with a proven diagnosis this had been established by excision biopsy in 94 and open incision biopsy in 48. By contrast, of those undiagnosed at referral, 44 of 51 patients with soft tissue sarcoma had the diagnosis made by Tru‐cut core biopsy. Amputation was performed in four of 165 patients with primary extremity soft tissue sarcoma and in five of 54 with recurrent extremity sarcoma, giving an overall amputation rate of 4 per cent. It is proposed that the amputation rate for extremity soft tissue sarcoma can be reduced by the use of reconstructive procedures, particularly myocutaneous flaps to the proximal limbs and limb girdles, and free vascularized flaps to sites distal to the midthigh and midarm.</abstract><relatedItem type="host"><titleInfo><title>British Journal of Surgery</title></titleInfo><titleInfo type="abbreviated"><title>Br J Surg</title></titleInfo><genre type="journal">journal</genre><subject><genre>article-category</genre><topic>Original Article</topic></subject><identifier type="ISSN">0007-1323</identifier><identifier type="eISSN">1365-2168</identifier><identifier type="DOI">10.1002/(ISSN)1365-2168</identifier><identifier type="PublisherID">BJS</identifier><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><detail type="issue"><caption>no.</caption><number>8</number></detail><extent unit="pages"><start>1136</start><end>1139</end><total>4</total></extent></part></relatedItem><identifier type="istex">03188AADB95347E856A2C88C9E551D3361A6BC90</identifier><identifier type="DOI">10.1002/bjs.1800810817</identifier><identifier type="ArticleID">BJS1800810817</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 1994 British Journal of Surgery Society Ltd.</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>John Wiley & Sons, Ltd.</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000143 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000143 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:03188AADB95347E856A2C88C9E551D3361A6BC90
|texte= Management of soft tissue sarcoma
}}
| This area was generated with Dilib version V0.6.31. |  |